Since overexpression of RAS p21 in the tumor tissue has been linked to worse survival, it might be hypothesized that the origin of circulating RAS p21 is the metastasis; however, no study so far examined the expression of RAS p21 in both tumor tissue and blood in the same subset of breast cancer patients and evidence from other entities is scarce. This evidence concerns the gene HRAS and breast cancer.